BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 11277172)

  • 1. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation.
    Pecora AL; Stiff P; LeMaistre CF; Bayer R; Bachier C; Goldberg SL; Parthasarathy M; Jennis AA; Smith AK; Douville J; Chen B; Armstrong RD; Mandalam RK; Preti R
    Bone Marrow Transplant; 2001 Aug; 28(3):295-303. PubMed ID: 11535999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
    Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
    Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
    Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
    Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
    Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.
    Zimmerman TM; Lee WJ; Bender JG; Schilling M; Smith SL; Van Epps DE; Williams SF
    Bone Marrow Transplant; 2000 Sep; 26(5):505-10. PubMed ID: 11019839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ig heavy chain CDR3 size diversities are similar after conventional peripheral blood and ex vivo expanded hematopoietic cell transplants.
    Gokmen E; Bachier C; Raaphorst FM; Muller T; Armstrong D; LeMaistre CF; Teale JM
    Bone Marrow Transplant; 2001 Feb; 27(4):413-24. PubMed ID: 11313671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer.
    Stiff P; Chen B; Franklin W; Oldenberg D; Hsi E; Bayer R; Shpall E; Douville J; Mandalam R; Malhotra D; Muller T; Armstrong RD; Smith A
    Blood; 2000 Mar; 95(6):2169-74. PubMed ID: 10706891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
    Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
    Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system.
    Koller MR; Manchel I; Maher RJ; Goltry KL; Armstrong RD; Smith AK
    Bone Marrow Transplant; 1998 Apr; 21(7):653-63. PubMed ID: 9578304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
    Drayer AL; Smit Sibinga CT; Esselink MT; de Wolf JT; Vellenga E
    Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials.
    Yang QE; Fong SE; Li K; Gonda MA; Tobin GJ
    Med Sci Monit; 2005 Jun; 11(6):BR154-161. PubMed ID: 15917709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.
    Brugger W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    N Engl J Med; 1995 Aug; 333(5):283-7. PubMed ID: 7541111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
    Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential.
    Traycoff CM; Cornetta K; Yoder MC; Davidson A; Srour EF
    Exp Hematol; 1996 Feb; 24(2):299-306. PubMed ID: 8641356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
    Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M
    Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
    Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow.
    Serrano F; Varas F; Bernad A; Bueren JA
    Bone Marrow Transplant; 1994 Dec; 14(6):855-62. PubMed ID: 7711665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.